DYN · Forms 3, 4, 5
Insider trades at Dyne Therapeutics, Inc.
1 insider bought $40K of Dyne Therapeutics, Inc. stock on the open market in the last 30 days.
Every Form 3, 4 and 5 filed for Dyne Therapeutics, Inc. (DYN) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Brian S Posner | Director | Buy | 2,500 | $16.00 | $40K | Form 4 | |
| Johanna Friedl-Naderer | Chief Commercial Officer | Sell (10b5-1 plan) | 185 | $18.88 | $3K | Form 4 | |
| Douglas Kerr | Chief Medical Officer | Sell (10b5-1 plan) | 1,290 | $18.88 | $24K | Form 4 | |
| John Cox | CEO & President | Sell (10b5-1 plan) | 5,658 | $18.88 | $107K | Form 4 | |
| Johanna Friedl-Naderer | Chief Commercial Officer | Sell (10b5-1 plan) | 900 | $24.35 | $22K | Form 4 | |
| Douglas Kerr | Chief Medical Officer | Sell (10b5-1 plan) | 3,745 | $24.35 | $91K | Form 4 | |
| Jason P Rhodes | Director | Sell (10b5-1 plan) | 1,359,674 | $25.00 | $34M | Form 4 | |
| Jason P Rhodes | Director | Sell (10b5-1 plan) | 478,377 | $25.00 | $12M | Form 4 | |
| Jason P Rhodes | Director | Sell (10b5-1 plan) | 322,465 | $25.00 | $8.1M | Form 4 | |
| Jason P Rhodes | Director | Sell (10b5-1 plan) | 268,354 | $26.20 | $7M | Form 4 | |
| Jason P Rhodes | Director | Sell (10b5-1 plan) | 94,415 | $26.20 | $2.5M | Form 4 | |
| Jason P Rhodes | Director | Sell (10b5-1 plan) | 63,643 | $26.20 | $1.7M | Form 4 | |
| Johanna Friedl-Naderer | Chief Commercial Officer | Sell (10b5-1 plan) | 226 | $26.28 | $6K | Form 4 | |
| Douglas Kerr | Chief Medical Officer | Sell (10b5-1 plan) | 1,556 | $26.28 | $41K | Form 4 | |
| John Cox | CEO & President | Sell (10b5-1 plan) | 4,986 | $26.28 | $131K | Form 4 | |
| Erick Lucera | Chief Financial Officer | Sell (10b5-1 plan) | 1,797 | $26.28 | $47K | Form 4 | |
| Dirk Kersten | Director | Sell (10b5-1 plan) | 256,072 | $25.50 | $6.5M | Form 4 | |
| Dirk Kersten | Director | Sell (10b5-1 plan) | 5,388 | $26.04 | $140K | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.